Sanofi Adds mRNA Specialist Tidal To Acquisition Spree

Focus Again On Cancer and Immunology

 
• By Andrew McConaghie
  
Sanofi building
Sanofi has made a string of acquisitions in the last 18 months, acquiring early and mid-stage companies and assets.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip